Despite substantial evidence that Roundup weed killer is safe and non-carcinogenic if used properly, a federal judge last week appointed attorney Kenneth Feinberg to oversee court-mandated settlement talks between Bayer AG (the company that owns Roundup’s producer, Monsanto) and plaintiffs who claim that the product caused their non-Hodgkin’s lymphoma.” (1).
For almost half a century, the International Agency for Research on Cancer (IARC) has run a Monographs programme, which has been the premier global resource for the identification of agents that cause cancer (2). The Monographs apply rigorous procedures for the scientific review and evaluation of carcinogenic hazards by independent experts, free from conflict of interest.
Since publishing Monograph conclusions on some pesticides (3), the IARC has been subject to intense efforts to undermine its evaluation and the whole organization.
SKT (KIAA1217) Antibody |
|||
| abx234542-100g | Abbexa | 100 µg | EUR 350 |
SKT (KIAA1217) Antibody |
|||
| abx234542-100ug | Abbexa | 100 ug | EUR 610.8 |
Mouse SKT shRNA Plasmid |
|||
| 20-abx980555 | Abbexa |
|
|
Mouse Sickle tail protein (SKT) ELISA Kit |
|||
| abx389166-96tests | Abbexa | 96 tests | EUR 687.5 |
Mouse Sickle tail protein, Skt ELISA KIT |
|||
| ELI-29595m | Lifescience Market | 96 Tests | EUR 1038 |
SKT (KIAA1217) (NM_019590) Human Over-expression Lysate |
|||
| E45H11013-2 | EnoGene | each | EUR 395 |
SKT (KIAA1217) (NM_019590) Human Over-expression Lysate |
|||
| LS056243 | BosterBio | 100ug | EUR 960 |
|
Description: Transient overexpression lysate of KIAA1217 (KIAA1217), transcript variant 1 |
|||
Recombinant Mouse Sickle tail protein (Skt) , partial |
|||
| MBS1201914-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Human Sickle tail protein homolog, SKT ELISA KIT |
|||
| ELI-18163h | Lifescience Market | 96 Tests | EUR 988.8 |
Recombinant Human Sickle tail protein homolog (SKT) , partial |
|||
| MBS1296028-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Skt ELISA Kit| Mouse Sickle tail protein ELISA Kit |
|||
| EF014796 | Lifescience Market | 96 Tests | EUR 826.8 |
JW 480 |
|||
| 465566 | MedKoo Biosciences | 50.0mg | EUR 450 |
SW 480 |
|||
| ABC-TC1186 | AcceGen | 1 vial | Ask for price |
|
Description: Human colon adenocarcinoma. Derived from a grade 3-4 colon adenocarcinoma. A cell line established from a lymph node metastasis taken from the same patient one year later is available. The initial cultures contained a mixture of epithelial and bipolar cells, but subsequently epithelial cells predominated. The cells produce CEA. The line is negative for CSAp (CSAp-) and colon antigen 3. The cells are positive for keratin by immunoperoxidase staining. There is a G -> A mutation in codon 273 of the p53 gene resulting in an Arg -> His substitution and a C -> T mutation in codon 309. |
|||
JW 480 |
|||
| B5556-10 | ApexBio | 10 mg | EUR 193.6 |
|
Description: Others|Hydroxylases |
|||
JW 480 |
|||
| B5556-25 | ApexBio | 25 mg | EUR 390 |
JW 480 |
|||
| B5556-5 | ApexBio | 5 mg | EUR 132 |
JW 480 |
|||
| B5556-50 | ApexBio | 50 mg | EUR 814.4 |
|
Description: Others|Hydroxylases |
|||
JW 480 |
|||
| J211933 | Toronto Research Chemicals | 100mg | EUR 1200 |
|
Description: 1354359-53-7 |
|||
JW 480 |
|||
| MBS5757360-100mg | MyBiosource | 100mg | EUR 505 |
JW 480 |
|||
| MBS5757360-10mg | MyBiosource | 10mg | EUR 175 |
JW 480 |
|||
| MBS5757360-25mg | MyBiosource | 25mg | EUR 250 |
JW 480 |
|||
| MBS5757360-50mg | MyBiosource | 50mg | EUR 345 |
JW 480 |
|||
| MBS5757360-5mg | MyBiosource | 5mg | EUR 150 |
JW 480 |
|||
| T22883-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: JW 480 |
|||
JW 480 |
|||
| T22883-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: JW 480 |
|||
JW 480 |
|||
| T22883-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: JW 480 |
|||
JW 480 |
|||
| T22883-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: JW 480 |
|||
JW 480 |
|||
| T22883-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: JW 480 |
|||
JW 480 |
|||
| TRC-J211933-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
J-111 |
|||
| ABC-TC0462 | AcceGen | 1 vial | Ask for price |
|
Description: Originally established from acute monocytic leukemia, HeLa-contaminated. |
|||
Hsp-111 |
|||
| 110080 | CH3 BioSystems | each | EUR 249 |
|
Description: Human |
|||
BML-111 |
|||
| abx282879-100g | Abbexa | 100 µg | Ask for price |
BML-111 |
|||
| abx282879-20g | Abbexa | 20 µg | EUR 118.75 |
BML-111 |
|||
| abx282879-50g | Abbexa | 50 µg | EUR 287.5 |
GXF-111 |
|||
| HY-153414 | MedChemExpress | Get quote | Ask for price |
|
Description: GXF-111, a PROTAC molecule, can promote selective degradation of cellular BRD3 and BRD4-L. GXF-111 has binding affinities for BRD3 BD1 and BRD3 BD2 with Ki values of 11.97 nM and 2.35 nM, respectively. GXF-111 can be used for the research of cancer[1]. |
|||
SKA-111 |
|||
| HY-100418 | MedChemExpress | 10 mg | EUR 205.63 |
|
Description: SKA-111 is a selective activator of potassium phannel KCa 3.1 , evokes KCa 3.1 membrane hyperpolarization in porcine endothelial cell. SKA-111 is capable of improving Bradykinin (HY-P0206)-induced coronary dilations in the isolated rat heart and can be used for cardiovascular disease research[1]. |
|||
BML-111 |
|||
| HY-100450 | MedChemExpress | 5 mg | EUR 735.94 |
|
Description: BML-111, a lipoxin A4 analog, is a lipoxin A4 receptor agonist. BML-111 represses the activity of angiotensin converting enzyme (ACE) and increases the activity of angiotensinconverting enzyme 2 (ACE2). BML-111 has antiangiogenic, antitumor and anti-inflammatory properties[1][2]. |
|||
CHS-111 |
|||
| HY-116730 | MedChemExpress | Get quote | Ask for price |
|
Description: CHS-111 is a benzyl indazole inhibitor of superoxide anion O2- generation. CHS-111 inhibits the cell migration, and reduces the formyl-Met-Leu-Phe- but not phorbol ester-stimulated phospholipase D activity, with the IC50 of 3.9 μM[1]. |
|||
VERU-111 |
|||
| MBS3843203-10mg | MyBiosource | 10mg | EUR 810 |
VERU-111 |
|||
| MBS3843203-50mg | MyBiosource | 50mg | EUR 2370 |
VERU-111 |
|||
| MBS3843203-5mg | MyBiosource | 5mg | EUR 465 |
VERU-111 |
|||
| MBS3843203-5x50mg | MyBiosource | 5x50mg | EUR 10655 |
BML-111 |
|||
| MBS565796-5mg | MyBiosource | 5mg | EUR 475 |
BML-111 |
|||
| MBS565796-5x5mg | MyBiosource | 5x5mg | EUR 1985 |
SKA-111 |
|||
| MBS5774544-5mg | MyBiosource | 5(mg | EUR 915 |
SKA-111 |
|||
| MBS5774544-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
CHS-111 |
|||
| MBS5776734-5mg | MyBiosource | 5(mg | EUR 915 |
CHS-111 |
|||
| MBS5776734-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
BML-111 |
|||
| MBS5773289-10mg | MyBiosource | 10mg | EUR 1200 |
BML-111 |
|||
| MBS5773289-5x10mg | MyBiosource | 5x10mg | EUR 5250 |
K-111 |
|||
| MBS5777411-5mg | MyBiosource | 5(mg | EUR 915 |
K-111 |
|||
| MBS5777411-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
CHS-111 |
|||
| T27013-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: CHS-111 |
|||
CHS-111 |
|||
| T27013-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: CHS-111 |
|||
CHS-111 |
|||
| T27013-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: CHS-111 |
|||
CHS-111 |
|||
| T27013-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: CHS-111 |
|||
CHS-111 |
|||
| T27013-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: CHS-111 |
|||
K-111 |
|||
| T27706-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: K-111 |
|||
K-111 |
|||
| T27706-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: K-111 |
|||
K-111 |
|||
| T27706-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: K-111 |
|||
K-111 |
|||
| T27706-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: K-111 |
|||
K-111 |
|||
| T27706-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: K-111 |
|||
SKA-111 |
|||
| T24799-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: SKA-111 |
|||
SKA-111 |
|||
| T24799-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: SKA-111 |
|||
SKA-111 |
|||
| T24799-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: SKA-111 |
|||
SKA-111 |
|||
| T24799-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: SKA-111 |
|||
SKA-111 |
|||
| T24799-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: SKA-111 |
|||
BML-111 |
|||
| T22526-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BML-111 |
|||
BML-111 |
|||
| T22526-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BML-111 |
|||
BML-111 |
|||
| T22526-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BML-111 |
|||
BML-111 |
|||
| T22526-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BML-111 |
|||
BML-111 |
|||
| T22526-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BML-111 |
|||
Laminin 111 |
|||
| RA22121 | Neuromics | 100 ul | EUR 292.5 |
ATF2 (Ab-480) Antibody |
|||
| 8B0819 | AAT Bioquest | 50ug | EUR 368 |
|
Description: ATF2 (Ab-480) Antibody |
|||
mFluorâ„¢ Violet 480 SE |
|||
| 1158 | AAT Bioquest | 1mg | EUR 208 |
|
Description: mFluorâ„¢ Violet 480 SE is reasonably stable and shows good reactivity and selectivity with protein amino groups. |
|||
mFluorâ„¢ Violet 480 SE |
|||
| 1158-1mg | AAT Bioquest | 1 mg | EUR 203 |
|
Description: mFluorâ„¢ Violet 480 SE is reasonably stable and shows good reactivity and selectivity with protein amino groups. |
|||
ATF2 (Ab-480) Antibody |
|||
| E11-0819B | EnoGene | 100μg | EUR 225 |
|
Description: Available in various conjugation types. |
|||
HTRA1 (161-480) Protein |
|||
| MBS517052-002mg | MyBiosource | 0.02mg | EUR 305 |
HTRA1 (161-480) Protein |
|||
| MBS517052-005mg | MyBiosource | 0.05mg | EUR 495 |
HTRA1 (161-480) Protein |
|||
| MBS517052-5x005mg | MyBiosource | 5x0.05mg | EUR 1965 |
ATF2 (Ab-480) Antibody |
|||
| MBS859682-01mg | MyBiosource | 0.1mg | EUR 305 |
ATF2 (Ab-480) Antibody |
|||
| MBS859682-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
ATF2 (Ab-480) Antibody |
|||
| MBS859682-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
ATF2 (Ab-480) Antibody |
|||
| MBS859682-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
ATF2 (Ab-480) Antibody |
|||
| MBS859682-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
Handheld Fluorometer 480/530nm |
|||
| FL480530 | BioAssay Systems | 1 unit | EUR 1886.4 |
|
Description: Compact handheld fluorometer (exc.480 and em.530nm) for quantitative determination of various analytes in life sciences R&D, food safety and environmental monitoring. Highly sensitive, rapid-reading, reliable and low cost. |
|||
nhr-111 Antibody |
|||
| CSB-PA526141XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans nhr-111 protein |
|||
nhr-111 Antibody |
|||
| CSB-PA526141XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans nhr-111 protein |
|||
Noopept (GVS-111) |
|||
| MBS130809-100mg | MyBiosource | 100mg | EUR 1065 |
Noopept (GVS-111) |
|||
| MBS130809-500mg | MyBiosource | 500mg | EUR 2775 |
Anticancer agent 111 |
|||
| HY-149977 | MedChemExpress | Get quote | Ask for price |
|
Description: Anticancer agent 111 (compound 11) is a potent cytochrome P450 inhibitor with an IC50 value of 3 μM for CYP3A4. Anticancer agent 111 has anticancer activity. Anticancer agent 111 can be used in research of cancer[1]. |
|||
Antitumor agent-111 |
|||
| HY-155544 | MedChemExpress | Get quote | Ask for price |
|
Description: Antitumor agent-111 (compound 46) is an c-Met kinase inhibitor (IC50=46 nM) with antitumor and antiproliferative activity. Antitumor agent-111 arrests cell cycle at G0/G1 phase, and induces apoptosis[1]. |
|||
Antibacterial agent 111 |
|||
| HY-147878 | MedChemExpress | Get quote | Ask for price |
|
Description: Antibacterial agent 111 (Compound 3) is an antibacterial agent with MIC values of 3.90 μg/mL and 0.49 μg/mL against B. cereus and K. pneumonia, respectively. Antibacterial agent 111 firmly binds with tyrosyl-tRNA synthetase residues[1]. |
|||
111-Undecanedicarboxylic acid |
|||
| MBS3610047-5mg | MyBiosource | 5mg | EUR 200 |
111-Undecanedicarboxylic acid |
|||
| MBS3610047-5x5mg | MyBiosource | 5x5mg | EUR 580 |
Antibacterial agent 111 |
|||
| T61123-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Antibacterial agent 111 |
|||
Antibacterial agent 111 |
|||
| T61123-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Antibacterial agent 111 |
|||
Antibacterial agent 111 |
|||
| T61123-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Antibacterial agent 111 |
|||
Antibacterial agent 111 |
|||
| T61123-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Antibacterial agent 111 |
|||
Antibacterial agent 111 |
|||
| T61123-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Antibacterial agent 111 |
|||
RTI-111-d3 |
|||
| R701102 | Toronto Research Chemicals | 50mg | EUR 7600 |
111-Trichloroethane - 1ML |
|||
| S3605 | Scientific Laboratory Supplies | 1ML | EUR 51.3 |
111-Trichloroacetone - 1ML |
|||
| S-3577 | Scientific Laboratory Supplies | 1ML | EUR 183.6 |
RTI-111-d3 |
|||
| TRC-R701102-50MG | Toronto Research Chemicals | 50 mg | Ask for price |
GVS-111/noopept |
|||
| A-NOO-1KG-01 | SW Technology Co., Ltd | 10 g | Ask for price |
GVS-111/noopept |
|||
| A-NOO-1KG-02 | SW Technology Co., Ltd | 100 g | Ask for price |
GVS-111/noopept |
|||
| A-NOO-1KG-03 | SW Technology Co., Ltd | 500 g | Ask for price |
GVS-111/noopept |
|||
| A-NOO-1KG-04 | SW Technology Co., Ltd | 1 Kg | Ask for price |
THT-21-480 AB Labels |
|||
| 104195 | BRADY NV | Roll of 1 Label(s) | EUR 544.16 |
|
Description: Description Dutch: Thermische transfert labels; Description French: Etiquettes imprimables par transfert thermique |
|||
THT-106-480 AB Labels |
|||
| 104196 | BRADY NV | Roll of 1 Label(s) | EUR 391.51 |
|
Description: Description Dutch: Thermische transfert labels; Description French: Etiquettes imprimables par transfert thermique |
|||